AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2024
Categories |
Back to Blog
The Glucose Excipient Market is estimated to be valued at US$ 1,058.2 Mn or Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Glucose excipient is widely used in formulations of different dosage forms like tablets, capsules, gels, syrups, suspensions etc. due to its excellent functionality as a filler, sweetener, humectant and bulking agent. Glucose is commonly used in many drug formulations designed to modify drug release as it displays excellent compressibility enabling the production of solid dosage forms. Market Dynamics: The market is witnessing growth owing to increasing demand for taste masking and enhancement applications using glucose. Additionally, rapid expansion of pharmaceutical industry along with high adoption of oral solid dosage forms is driving the glucose excipient market growth. Moreover, glucose is preferred for fast dissolving tablet formulations which provides quick medicinal dosing to pediatric and geriatric patients having difficulty in swallowing conventional tablets or capsules. However, rising penetration of alternative excipients might hamper the market growth over the forecast period. Segment Analysis The glucose excipient market is dominated by the pre-gelatinized starch segment. Pre-gelatinized starch accounts for over 40% of the overall market share due to its wide application in solid dosage formulations such as tablets and capsules. It provides excellent compression and elongation properties for direct compression processes. PEST Analysis Political: Stringent regulations regarding pharmaceutical excipient manufacturing may impact market growth. For instance, regulations under CGMP and International Council for Harmonisation guidelines. Economic: Growth of the pharmaceutical industry in emerging economies and economic stability in developed nations driving greater demand for pharmaceutical manufacturing inputs like excipients. Social: Increasing population and lifestyle diseases like diabetes boosting need for glucose-based medications and supplements. Technological: Advancements in modified release drug formulations requiring specialized excipients to affect dissolution behavior and enhance bioavailability. Key Takeaways The Global Glucose Excipient Market Demand is expected to witness high growth, exhibiting CAGR of 3.3% over the forecast period, due to increasing prevalence of diabetes and rising generic drug production. The market size for 2023 is estimated at US$ 1,058.2 Mn. Regional analysis indicates North America dominates the market currently due to strong pharmaceutical industry presence and favorable regulations. However, Asia Pacific is expected to emerge as the fastest growing regional market owing to rising incomes, healthcare infrastructure investment and expansion of domestic pharmaceutical manufacturing facilities. Key players operating in the glucose excipient market are Roquette Frà ̈res, Cargill, Incorporated, Ingredion Incorporated, Archer Daniels Midland Company, Grain Processing Corporation, Merck KGaA, DFE Pharma, Hilmar Ingredients, Karo Syrup, Gulshan Polyols Ltd., Tereos Group, Tate & Lyle PLC, Suzhou Hope Technology Co., Ltd., The Honjo Chemical Corporation, MAFCO Worldwide LLC. Major strategic activities include new product launches, capacity expansions and mergers & acquisitions to strengthen global supply networks and market position. Read More: https://www.pressreleasebulletin.com/glucose-excipient-market-forecast-market-share-and-insights/
0 Comments
Read More
Leave a Reply. |